Avecho Biotechnology Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was AUD 4.238 million compared to AUD 1.394 million a year ago. Net income was AUD 849,955 compared to net loss of AUD 3.991 million a year ago. Basic earnings per share from continuing operations was AUD 0.0005 compared to basic loss per share from continuing operations of AUD 0.0025 a year ago.